Dexamfetamine Sulfate Oral Solution
Dexamfetamine Sulfate is an oral liquid medicine that’s used to treat Narcolepsy and ADHD.
Dexamfetamine Sulfate is also indicated for:
Treatment of narcolepsy in adults.
Dexamfetamine is also indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years, when response to previous methylphenidate treatment is considered clinically inadequate. A comprehensive treatment programme typically includes psychological, educational and social measures.
Diagnosis should be made according to DSM-5 criteria or the guidelines in ICD-10 and should be based on a comprehensive multidisciplinary evaluation of the patient.
Dexamfetamine Sulfate is not indicated in all children with ADHD and the decision to use dexamfetamine must be based on a very thorough assessment of the severity and chronicity of the child’s symptoms in relation to the child’s age and potential for abuse, misuse or diversion.
Treatment should be under the supervision of a specialist in childhood and/or adolescent behavioural disorders.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Dexamfetamine Sulfate Oral Solution. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Dexamfetamine Sulfate Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.
Dexamfetamine Sulfate Oral Solution
| Click here for Audio Version | |
| Flavour | Orange tangerine |
| Storage Conditions | Store the bottle in an upright position |
| Sucrose Free | |
| Shelf Life (Closed Bottle/Open Bottle) | 4 years/30 days |
| PIP Code | 1204627 |
| EAN Code | 5016119000850 |
| Sodium Levels | Essentially sodium-free |
| Ethanol Concentration | None |
Downloads
Adverse Events
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk
Adverse events should also be reported to Rosemont at 0113 244 1400 or pharmacovigilance@rosemontpharma.com.
Contact us
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.
Related Products
